Lupin Limited (NSE:LUPIN)
India
· Delayed Price · Currency is INR 2,303.00
-21.50 (-0.92%)
Apr 28, 2026, 3:30 PM IST
Lupin Employees
Lupin had 24,006 employees as of March 31, 2025. The number of employees increased by 2,138 or 9.78% compared to the previous year.
Employees
24,006
Change (1Y)
2,138
Growth (1Y)
9.78%
Revenue / Employee
10.89M INR
Profits / Employee
1.93M INR
Market Cap
1,052.47B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Cipla | 30,313 |
| Mankind Pharma | 19,620 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Divi's Laboratories | 10,542 |
| Glenmark Pharmaceuticals | 15,800 |
| Alkem Laboratories | 18,785 |
| Laurus Labs | 6,167 |
Lupin News
- 6 days ago - Lupin launches Dapagliflozin and Metformin Extended-Release Tablets in the U.S. after FDA approval - Business Upturn
- 4 weeks ago - Lupin Receives Tentative U.S. FDA Approval For Sugammadex Injection - Nasdaq
- 4 weeks ago - Lupin receives tentative approval from U.S. FDA for Sugammadex Injection - Business Upturn
- 4 weeks ago - Lupin subsidiary Nanomi increases stake in Multicare Pharmaceuticals Philippines to 56.28% - Business Upturn
- 4 weeks ago - Lupin receives tentative U.S. FDA approval for Pitolisant Tablets - Business Upturn
- 5 weeks ago - Lupin announces expansion of Dabhasa manufacturing facility - Business Upturn
- 7 weeks ago - Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESG Assessment 2025 - Business Upturn
- 2 months ago - Lupin Goa facility clears US FDA inspection with VAI classification - Business Upturn